Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance

Journal of Virological Methods

Volumn 195, Issue , 2014, Pages 148-155

  Iwai Itamochi, Masae ^a   Yoshida, Hiromu ^b   Obara Nagoya, Mayumi ^a   Horimoto, Eiji ^a   Kurata, Takeshi ^a   Takizawa, Takenori ^a  

^a TOYAMA INSTITUTE OF HEALTH   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Environmental surveillance; Poliovirus; Real time PCR; Vaccine

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENVIRONMENTAL MONITORING; GENE DOSAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEWAGE TREATMENT; VIRUS CULTURE; VIRUS DETECTION; VIRUS TITRATION;

ENVIRONMENTAL SURVEILLANCE; POLIOVIRUS; REAL-TIME PCR; VACCINE;

ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; REAL-TIME POLYMERASE CHAIN REACTION; SEWAGE;

EID: 84887258688     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.10.004     Document Type: Article

References (36)

1. Alexander L.N., Seward J.F., Santibanez T.A., Pallansch M.A., Kew O.M., Prevots D.R., Strebel P.M., Cono J., Wharton M., Orenstein W.A., Sutter R.W. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 2004, 292:1696-1701.
2. Alexander J.P., Ehresmann K., Seward J., Wax G., Harriman K., Fuller S., Cebelinski E.A., Chen Q., Jorba J., Kew O.M., Pallansch M.A., Oberste M.S., Schleiss M., Davis J.P., Warshawsky B., Squires S., Hull H.F. Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J. Infect. Dis. 2009, 99:391-397.
3. Armbruster D.A., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 2008, 29:S49-S52.
4. Balanant J., Guillot S., Candrea A., Delpeyroux F., Crainic R. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 1991, 184:645-654.
5. Burd E.M. Validation of laboratory-developed molecular assays for infectious diseases. Clin. Microbiol. Rev. 2010, 23:550-576.
6. DeVries A.S., Harper J., Murray A., Lexau C., Bahta L., Christensen J., Cebelinski E., Fuller S., Kline S., Wallace G.S., Shaw J.H., Burns C.C., Lynfield R. Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N. Engl. J. Med. 2011, 364:2316-2323.
7. Ghendon Y., Robertson S.E. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations. Bull. World Health Organ. 1994, 72:973-983.
8. Infectious Agents Surveillance Center in Japan Poliomyelitis, Japan, 1962-1995. IASR 1997, 18:1-2. (in Japanese).
9. Iwai M., Hasegawa S., Obara M., Nakamura K., Horimoto E., Takizawa T., Kurata T., Sogen S., Shiraki K. Continuous presence of noroviruses and sapoviruses in raw sewage reflects infections among inhabitants of Toyama, Japan (2006 to 2008). Appl. Environ. Microbiol. 2009, 75:1264-1270.
10. Iwai M., Nakamura K., Obara M., Horimoto E., Hasegawa S., Kurata T., Takizawa T. Environmental surveillance of poliovirus to trace transmission among inhabitants. IASR 2009, 30:180-181. (in Japanese).
11. Jorba J., Campagnoli R., De L., Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J. Virol. 2008, 82:4429-4440.
12. Katayama H., Shimasaki A., Ohgaki S. Development of a virus concentration method and its application to detection of enterovirus and norwalk virus from coastal seawater. Appl. Environ. Microbiol. 2002, 68:1033-1039.
13. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 2005, 59:587-635.
14. Kilpatrick D.R., Nottay B., Yang C.F., Yang S.J., Mulders M.N., Holloway B.P., Pallansch M.A., Kew O.M. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J. Clin. Microbiol. 1996, 34:2990-2996.
15. Kilpatrick D.R., Nottay B., Yang C.F., Yang S.J., Silva E.D., Peñaranda S., Pallansch M., Kew O. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J. Clin. Microbiol. 1998, 36:352-357.
16. Kilpatrick D.R., Yang C.F., Ching K., Vincent A., Iber J., Campagnoli R., Mandelbaum M., De L., Yang S.J., Nix A., Kew O.M. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J. Clin. Microbiol. 2009, 47:1939-1941.
17. Li B., Kadura I., Fu D.J., Watson D.E. Genotyping with TaqMAMA. Genomics 2004, 83:311-320.
18. Matsuura K., Hasegawa S., Nakayama T., Morita O., Uetake H. Viral pollution of the rivers in Toyama City. Microbiol. Immunol. 1984, 28:575-588.
19. Matsuura K., Ishikura M., Yoshida H., Nakayama T., Hasegawa S., Ando S., Horie H., Miyamura T., Kitamura T. Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in Toyama prefecture. Appl. Environ. Microbiol. 2000, 66:5087-5091.
20. Minor P.D., Ferguson M., Evans D.M., Almond J.W., Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 1986, 67:1283-1291.
21. Minor P.D., Ferguson M., Katrak K., Wood D., John A., Howlett J., Dunn G., Burke K., Almond J.W. Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4. J. Gen. Virol. 1991, 72:2475-2481.
22. National Institute of Infectious Diseases in Japan (NIID) Annual Report on Findings of Infectious Agents in Japan 2008. Jpn. J. Infect. Dis. 2009, 62(Suppl.):96-123. http://www0.nih.go.jp/JJID/Suppl/Suppl62-4.pdf.
23. Onorato I.M., Modlin J.F., McBean A.M., Thoms M.L., Losonsky G.A., Bernier R.H. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J. Infect. Dis. 1991, 163:1-6.
24. Perkins S.M., Webb D.L., Torrance S.A., El Saleeby C., Harrison L.M., Aitken J.A., Patel A., DeVincenzo J.P. Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J. Clin. Microbiol. 2005, 43:2356-2362.
25. Patel V., Ferguson M., Minor P.D. Antigenic sites on type 2 poliovirus. Virology 1993, 192:361-364.
26. Rico-Hesse R., Pallansch M.A., Nottay B.K., Kew O.M. Geographic distribution of wild poliovirus type 1 genotypes. Virology 1987, 160:311-322.
27. Roivainen M., Blomqvist S., Al-Hello H., Paananen A., Delpeyroux F., Kuusi M., Hovi T. Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Euro. Surveill. 2010, 15. pii/19566. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19566.
28. Sachs L.A., Schnurr D., Yagi S., Lachowicz-Scroggins M.E., Widdicombe J.H. Quantitative real-time PCR for rhinovirus, and its use in determining the relationship between TCID50 and the number of viral particles. J. Virol. Methods 2011, 171:212-218.
29. Shimizu H. Poliomyelitis as of 2009. IASR 2009, 30:171-176. (in Japanese).
30. Shimojo H. Poliomyelitis control in Japan. Rev. Infect. Dis. 1984, 6(Suppl. 2):S427-S430.
31. Takatsu T., Tagaya I., Hirayama M. Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine. Bull. World Health Organ. 1973, 49:129-137.
32. Troy S.B., Ferreyra-Reyes L., Huang C., Mahmud N., Lee Y.J., Canizales-Quintero S., Flaster H., Báez-Saldaña R., García-García L., Maldonado Y. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a Mexican national immunization day. J. Clin. Microbiol. 2011, 49:1777-1783.
33. World Health Organization (WHO) Global Polio Eradication Initiative. Strategic Plan 2010-2012 2010, http://www.polioeradication.org/content/publications/gpei.strategicplan.2010-2012.eng.may.2010.pdf.
34. WHO Monitoring progress towards global polio eradication: poliovirus surveillance, 2009-2010. Weekly Epidemiol. Rec. 2011, 86:153-160.
35. Yoshida H., Li J., Yoneyama T., Yoshii K., Shimizu H., Nguyen T.H., Toda K., Nguyen T.L., Phan V.T., Miyamura T., Hagiwara A. Two major strains of type 1 wild poliovirus circulating in Indochina. J. Infect. Dis. 1997, 175:1233-1237.
36. Zurbriggen S., Tobler K., Abril C., Diedrich S., Ackermann M., Pallansch M.A., Metzler A. Isolation of Sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl. Environ. Microbiol. 2008, 74:5608-5614.